| Title： | Chinese multidisciplinary consensus on the clinical management of patients with endometrial cancer |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Members in Gynecologic Oncology multidisciplinary team |
| Evidence classification method： | Level of Evidence Category 1 Phase III randomized controlled clinical trial and/or meta-analysis Category 2 Prospective clinical studies or small randomized controlled clinical trials Category 3 Case report or extensive clinical experience |
| Development unit： | The Society of Gynecological Cancer of China Anti-Cancer Association |
| Registration time: | 2023-05-11 |
| Registration number： | PREPARE-2023CN329 |
| Purpose of the guideline: | Summarize the evidence and interdisciplinary opinions on complex or challenging issues requiring multidisciplinary decision-making in endometrial cancer. Support MDT team to improve individualized treatment for endometrial cancer patients in China |
